Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Industrial Production & Applications of Amino Acids: L-Glutamine & Glutamic Acid, Lecture notes of Pharmacology

An overview of the industrial production and applications of amino acids, with a focus on l-glutamine and glutamic acid. It covers the history of amino acid production, worldwide consumption and demand, major uses in research and analytical applications, medical and pharmaceutical uses, and manufacturing methods. The document also discusses the effects of different dissolved oxygen (do) levels on glutamate fermentation and the metabolic balance between glycolysis, glutamate synthesis, and tca metabolic flux.

What you will learn

  • What is the worldwide consumption of L-Glutamic Acid?
  • What are the medical and pharmaceutical applications of L-Glutamic Acid?
  • What is the history of the discovery of L-Glutamic Acid?
  • What are the major uses of glutamic acid and its derivatives in research?
  • What is the manufacturing process of L-Glutamic Acid by fermentation?

Typology: Lecture notes

2017/2018

Uploaded on 04/24/2018

suraj-patil-2
suraj-patil-2 🇮🇳

3.9

(11)

4 documents

1 / 47

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
1
Background
Industrial production of amino acids have started with availability of
monosodium glutamate (MSG) in 1909
Discovered by Dr.Kikunae Ikeda in 1908
Originally manufactured by extraction from acid hydrolysis of plant protein
In late 1950 fermentation technology was established and commercially
exploited for other amino acids
L-Glutamine fermentation started in late 1960
Kusumoto I., Journal of Nutrition. 2001; 131:2552-2555.
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f

Partial preview of the text

Download Industrial Production & Applications of Amino Acids: L-Glutamine & Glutamic Acid and more Lecture notes Pharmacology in PDF only on Docsity!

1

Background

  • Industrial production of amino acids have started with availability of monosodium glutamate (MSG) in 1909
  • Discovered by Dr. Kikunae Ikeda in 1908
  • Originally manufactured by extraction from acid hydrolysis of plant protein
  • In late 1950 fermentation technology was established and commercially exploited for other amino acids
  • L-Glutamine fermentation started in late 1960

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

2

Consumption and production

  • Worldwide consumption of amino acids is about 2 million tonnes
  • About 1.5 million tonnes was sold in 2001
  • 4% annual growth in sale is observed
  • The annual demand of amino acids in food and pharmaceutical industry is 4,60,000 tonnes
  • The annual worldwide production of L-glutamine is 3,70,000 tonnes

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

4

Table 1 - Major uses of glutamic acid and its derivatives in research PROTEIN ENGINEERING Peptide synthesis Protein modification Polymer supports BIOCHEMICAL/CELL BIOLOGY Biochemical experiments Cell biology research ANALYTICAL APPLICATIONS Analytical standards Diagnostic products and procedures

Table 2 - Analytical uses of glutamic acid and its derivatives Gas chromatography

Pure glutamic acid or derivatives

Research, medical, food processing Affinity chromatography

Glutamic acids bonded to polymer and other types

Separating complex proteins/high molecular weight materials Radioisotope tracers

Radiolabelled liquid or solid

Medical, pharmaceutical

Table 3 - Medical and pharmaceutical applications TREATING DISEASE Parenteral nutrition, Prescription dietary supplements, Congenital metabolic diseases, Hypertension, Neuroregulators, Ophthalmic solutions DIAGNOSING DISEASE (^) Congenital metabolic diseases, Disorders or malfunction of brain/nervous system

5

 ENTERAL NUTRITION  Crystalline glutamic acid in solution: It is the source of protein precursors for hospitalized patients unable to eat or eat enough to get or stay healthy.

 PARENTERAL NUTRITION

Crystalline glutamic acid in solution: Given to the patient through circulatory system via a vein

 PRESCRIPTION DIETARY SUPPLEMENTS

Tablet, capsule or powder protein precursors: For people able to eat but who need very highly concentrated source to recover from illness or surgery

 CONGENITAL METABOLIC DISEASES  Powder Prescription diets: For newborn babies and others who need a diet devoid of or with highly reduced content of specific amino acid

 HYPERTENSION (Capsules or injection)

Prescription drugs that reduce blood pressure

 NEURO-REGULATORS (Capsules or injection)

Therapeutic applications of glutamic acid

7

General manufacturing process

 The manufacturing methods of amino acids are-

 Extraction from acid hyrolysates  Chemical synthesis  Fermentation  Enzymatic

 Leucine, proline, tyrosine, cystine are manufactured by extraction, fermentation and chemical synthesis

 L-Glutamic acid is manufactured world wide using fermentation

 The manufacturing process of an amino acid by fermentation comprises fermentation, crude isolation and purification processes.

 In the crude isolation process, most impurities contained in the fermentation broth are removed by combining various technologies

Contd…..

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

8

 Final purification is performed to ensure the required quality for the intended use

 The final product is obtained as a crystalline powder

 The product is released only after quality tests have verified that the product meets specific requirements, and the normal functioning of each process step has been verified

 All manufacturing processes for the production of amino acids for medical use must comply with current good manufacturing practice requirements

10

Schematic representation of glutamic acid production

11

Strains producing glutamic acid

 Most exploited is Corynebacterium glutamicum

 Other genera of Corynebacterium is also used

 Brevibacterium sp. , Microbacterium sp. , Arthrobacter sp. are

also used

 All glutamic acid producers require biotin for their activity

 All the strains show little activity of α-ketoglutarate

dehydrogenase

 Increased activity of glutamate dehydrogenase

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

13

Conditions of manufacture

 Carbon sources: glucose, sucrose, maltose, xylose, sugarcane and

sugarbeet, molasses, strach, hydrolysates

 Nitrogen sources: ammonium salts, ammonia, urea

 Growth factors: biotin, L-cystiene

 Oxygen supply:

 Optimal production occurs at K d of 0.0000035 moles of O 2 /

atm.min.ml

 Lower oxygen content causes excretion of lactate

 Higher oxygen content inhibits α-ketoglutarate production

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

14

Culture medium

Seed culture

  • Glucose – 40 g
  • K 2 HPO 4 – 1 g
  • MgSO 4 – 0.5 g
  • Urea – 8 g
  • Tap water – 1 litre
  • Incubation for 16 h at 35 0 C

Main culture

  • Glucose – 40g
  • K 2 HPO 4 – 1g
  • MgSO 4 – 0.5g
  • K 2 SO 4 – 1.2g
  • FeSO 4 – 6ppm
  • MnSO 4 - 6ppm
  • CH 3 COONH 4 – 5g
  • Antifoam agent – Hodag K- 67 (0.1ml)
  • Tap water – 1 litre
  • Innoculum volume – 6%

16

Overview of fermentation

17

Fermented broth Centifugation Collect supernatant

Concentration Ion exchange treatment

Direct Crystallization Resin preparation

Column packing

Separation of fluid (acidified to pH 3.2, with 1 N HCl. Storage at 20°C for 48 h)

Crystallization

Downstream Processing

K. Madhavan Nampoothiri et al; Revista de microbiologta. 1999; 30.

19

Flow diagram of the isolation process.

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.

20

Effect of temperature on solubility of glutamate

  • The solubility of L-Gln is barely affected by temperature as shown by the flat solubility curve.
  • Consequently, cooling crystallization is not applicable for harvesting L-Gln.

Kusumoto I., J ournal of Nutrition. 2001 ; 131:2552-2555.